|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10 USD | -1.19% |
|
+11.86% | -30.12% |
| Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
| Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 | MT |
OptimizeRx Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 71.52 million compared to USD 62.45 million a year ago. Net loss was USD 17.57 million compared to USD 11.44 million a year ago.
Basic loss per share from continuing operations was USD 1.03 compared to USD 0.64 a year ago. Diluted loss per share from continuing operations was USD 1.03 compared to USD 0.64 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.12% | 184M | |
| +18.39% | 414B | |
| +14.91% | 242B | |
| +9.47% | 144B | |
| +19.18% | 104B | |
| +16.86% | 83.87B | |
| +52.33% | 57.64B | |
| +33.60% | 53.37B | |
| +5.85% | 37.83B | |
| +15.64% | 34.11B |
OPTIMIZERX CORPORATION 
